HRA must continue ‘progress towards clinical trial transparency’
August 19, 2015Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency
Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …
Kite Pharma says trial death was unrelated to KTE-C19
August 18, 2015Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma
Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
Biogen collaborates with ALSA and Columbia University on genomic-based ALS treatments
August 18, 2015Research and Development
Biogen, the ALS Association and Columbia University Medical Center (CUMC) have announced a new collaboration aimed at better understanding the differences …
Birmingham opens BioHub for life science start-ups
August 18, 2015Manufacturing and Production Birmingham, Diagnostics, hubs, life sciences, research hubs, start-ups
A £7 million biomedical laboratory has opened in Birmingham to attract life-science researchers and start-ups. The BioHub is a new …
New NICE guidelines to tackle antibiotic ‘addiction’
August 18, 2015Manufacturing and Production AMR, Antibiotics, NICE, antimicrobial resistance, guidance, infections
NICE has published guidance to help health care professionals promote and monitor the sensible use of antibiotics – and support …
Roche lung cancer therapy succeeds in mid-stage trial
August 17, 2015Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer
Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …
FDA approves limited OxyContin use in children
August 17, 2015Sales and Marketing FDA, OxyContin, Purdue, Purdue Pharma, oxycodone
The FDA has approved the limited use of the strong painkiller Oxycontin for children in the US aged between 11 …
Google to expand diabetes monitoring technology
August 14, 2015Medical Communications blood sugar, diabetes, glucose, google, smart technology, wearable tech
Google is teaming up with the diabetes device maker DexCom to build a small and affordable sensor that could help …
Tamzin Redston joines Wave
August 14, 2015Medical Communications Tamzin Redston, Wave communications
Tamzin Redston has been appointed programme director at Wave, the specialist medical education company.Tamzin joins Wave with a background of …
Merck in immuno-oncology collaboration with major cancer research centre
August 14, 2015Research and Development Cancer, Merck, keytruda, oncology
Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
GSK closes Legionella-hit US site
August 14, 2015Manufacturing and Production GSK, Legionnaire's disease, legionella, manufacturing, production
GSK has temporarily shut down its manufacturing site in North Carolina due to the discovery of the bacteria which causes …
Bayer’s complaint over ‘misleading’ Novartis eye drug claims upheld
August 14, 2015Medical Communications Bayer, Eylea, Lucentis, Novartis, PMCPA, code of conduct
The industry’s code of conduct regulator has ruled in favour of Bayer in a dispute claims made by Novartis when …
Pfizer offers to pay for UK Lyrica switches
August 13, 2015Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin
Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …
Abbvie and Roche report success in Phase II leukaemia trial
August 13, 2015Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax
AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …
Cost of diabetes treatment in England rises
August 12, 2015Manufacturing and Production, Sales and Marketing HSCIC, NHS, diabetes, health and social care information centre, prescribing
As diabetes patients increase in numbers the cost of treating the disease in England has increased to more than £800 …
Orexigen and Takeda reboot Contrave collaboration
August 12, 2015Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs
Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …
FDA warns drugmaker over Kim Kardashian West promo
August 12, 2015Sales and Marketing Diclegis, Duchesnay, FDA, kim kardashian
Model and media personality Kim Kardashian West’s social media promotion of the morning sickness drug Diclegis has landed its producer …
Novavax rides high on crest of RSV vaccine wave
August 12, 2015Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines
The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
Gareth Thurston joins Cello Health Consulting
August 12, 2015Medical Communications Cello, Gareth Thurston, cello health
Cello Health has appointed Gareth Thurston as a consultant following his prior experience in pharmaceutical marketing. Gareth has over 20 …
Bristol-Myers Squibb launches Opdivo in the UK for lung cancer
August 12, 2015Sales and Marketing BMS, Bristol-Myers Squibb, NSCLC, immunotherapy, lung cancer, non small cell lung cancer, non-small cell lung cancer, opdivo
The immuno-oncology drug Opdivo is available in the UK for people with lung cancer, after Bristol-Myers Squibb launched the drug …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
